IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops

Oncogene

Volumn 16, Issue 19, 1998, Pages 2503-2512

  Barzegar, Cathy ^a   Meazza, Raffaella ^b   Pereno, Raffaele ^a   Pottin Clemenceau, Corinne ^a   Scudeletti, Marco ^c   Brouty Boyé, Daniele ^a   Doucet, Christelle ^a   Taoufik, Yassine ^d   Ritz, Jerome ^e   Musselli, Cristina ^c   Mishal, Zohar ^f   Jasmin, Claude ^a   Indiveri, Francesco ^c   Ferrini, Silvano ^b   Azzarone, Bruno ^a,c  

^a HÔPITAL PAUL BROUSSE   (France)

^b CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d INSERM   (France)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f CNRS   (France)

Author keywords

IL 15; IL 15R; Melanomas; Secretion pattern; Tumor progression immunotherapy

Indexed keywords

CYTOKINE ANTIBODY; HLA ANTIGEN CLASS 1; INTERLEUKIN 15; MESSENGER RNA; TUMOR MARKER;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 7144262412     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201775     Document Type: Article

References (34)

1. Alileche A, Plaisance S, Han D, Rubinstein E, Mingari M, Bellomo R, Jasmin C and Azzarone B. (1993). Oncogene, 8, 1791-1796.
2. Altomonte M, Colizzi F, Esposito G and Maio M. (1992). New England J. Med., 327, 959-961.
3. Anderson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, Loomis A, Giri J, Copeland NG, Gilbert DJ, Jenkins NJ, Valentine V, Shapiro DN, Park LS and Cosman D. (1995). J. Biol. Chem., 270, 29862-29869.
4. Armilage RJ, Macduff BM, Eiserman J, Paxton R and Grabstein K. (1995). J. Immunol., 154, 483-490.
5. Azzarone B, Pottin-Clemenceau C, Krief P, Rubinstein E, Jasmin C, Scudeletti M and Indiveri F. (1996). Eur. Cytokine Netw., 7, 27-36.
6. Bamford RN, Battiata AP, Burton JD, Sharma H and Waldmann TA. (1996). Proc. Natl. Acad. Sci. USA, 93, 2897-2902.
7. Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E and Waldmann TA. (1994). Proc. Natl. Acad. Sci. USA, 91, 4940-4944.
8. Caré A, Silvani E, Meccia G, Mati A, Stopacciaro G, Parmiani C, Peschele C and Colombo MP. (1996). Mol. Cell. Biol., 16, 4842-4851.
9. Carson WE, Giri JG, Lindermann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein KH and Caligiuri MA. (1994). J. Exp. Med., 180, 1395-1403.
10. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K and Caliguri MA. (1996). J. Clin. Invest., 96, 2578-2582.
11. Chomczynski P and Sacchi N. (1987). Analytical Biochem., 162, 156-159.
12. DeJong JLO, Farmer NL, Widmer MB, Giri JG and Sondel PM. (1996). J. Immunol., 156, 1339-1348.
13. Doucet C, Meazza R, Pottin-Clémenceau C, Scudeletti M, Brouty-Boyé D, Ferrini S, Alilèche A, Taoufik Y, Jasmin C, Azzarone B and Indiveri F. (1997). Melanoma Res., 7 supp, 75-175.
14. Ferrini S, Azzarone B and Jasmin C. (1996). Gene Ther., 3, 656-657.
15. Gamero AM, Ussery D, Reintgen DS, Puleo CA and Djeu JY. (1995). Cancer Res., 55, 4988-4994.
16. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D and Anderson D. (1994). EMBO J., 13, 2822-2830.
17. Giri JG, Kumaki S, Ahdied M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS and Anderson DM. (1995). EMBO J., 14, 3654-3663.
18. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Berrs C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson JD and Giri JG. (1994). Science, 264, 965-968.
19. Hans DS, Pottin-Clemenceau C, Imro MA, Scudeletti M, Doucet C, Puppo F, Brouty-Boyé D, Vedrenne J, Sahraoui Y, Brailly H, Poggi A, Jasmin C, Azzarone B and Indiveri F. (1996). Oncogene, 8, 1015-1023.
20. Katano M, Matsuo T, Morisaki T, Naito K, Nagumo F, Kubota E, Nakamura M, Hisatsugu T and Tadano J, (1994). Cancer Immunol. Immunother., 39, 161-166.
21. Kawahara A, Minami Y and Taniguchi T. (1994). Mol. Cell. Biol., 14, 5433-5440.
22. Kawami H, Yoshida K, Yamaguchi Y, Saeki T and Toge T. (1993). Biotherapy, 6, 33-39.
23. Lenter M and Vestweber D. (1994). J. Biol. Chem., 269, 12263-12268.
24. Meazza R, Verdiani S, Biassoni R, Coppolecchia M, Gaggero A, Orengo AM, Colombo MP, Azzarone B and Ferrini S. (1996). Oncogene, 12, 2187-2192.
25. Meazza R, Gaggero A, Neglia F, Basso S, Sforzini S, Pereno R, Azzarone B and Ferrini S. (1997). Eur. J. Immunol. in press.
26. Mohamadzadeh M, Tashima A, Dougherty I, Knop J, Bergstresser PR and Cruz PD. (1995). J. Immunol., 155, 4492-4496.
27. Morimoto K, Robin E, Le Bousse-kerdiles MC, Li Y, Clay D, Jasmin C, Smadja-Joffe F. (1994). Blood, 83, 657-662.
28. Mrozek E, Anderson P and Caligiuri MA. (1996). Blood, 87, 2632-2640.
29. Nakarai T, Robertson MJ, Streuli M, Wu Z, Ciardelli TL, Smith KA and Ritz J. (1994). J. Exp. Med., 180, 241-251.
30. Plaisance S, Rubinstein E, Alileche A, Han D, Sahraoui Y, Mingari M, Bellomo R, Rimoldi D, Colombo MP, Jasmin C, Carrel S and Azzarone B. (1993). Int. J. Cancer., 55, 164-170.
31. Rimoldi D, Salvi S, Hartmann F, Schreyer M, Blum S, Zografos L, Plaisance S and Carrel S. (1993). Anticancer Res., 13, 555-564.
32. Tagaya Y, Bamford RN, Defilippis AP and Waldmann TA. (1996a). Immunity, 4, 329-336.
33. Tagaya Y, Burton JD, Miyamoto Y and Waldmann TA. (1996b). KMBO J., 15, 4928-4939.
34. Waldmann TA. (1993). Immunol. Today, 14, 264-269.